Boye KS - Search Results

1

Medication adherence and improved outcomes among patients with type 2 diabetes.

Curtis SE, Boye KS, Lage MJ, Garcia-Perez LE. Curtis SE, et al. Among authors: boye ks. Am J Manag Care. 2017 Jul 1;23(7):e208-e214. Am J Manag Care. 2017. PMID: 28850793 Free article.

2

Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy.

Lage MJ, Fabunmi R, Boye KS, Misurski DA. Lage MJ, et al. Among authors: boye ks. Adv Ther. 2009 Feb;26(2):217-29. doi: 10.1007/s12325-009-0002-0. Epub 2009 Feb 14. Adv Ther. 2009. PMID: 19219409

3

A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine.

Misurski D, Lage MJ, Fabunmi R, Boye KS. Misurski D, et al. Among authors: boye ks. Appl Health Econ Health Policy. 2009;7(4):245-54. doi: 10.1007/BF03256158. Appl Health Econ Health Policy. 2009. PMID: 19905038

4

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.

Eby EL, Boye KS, Lage MJ. Eby EL, et al. Among authors: boye ks. J Med Econ. 2013 Oct;16(10):1231-7. doi: 10.3111/13696998.2013.823091. Epub 2013 Jul 23. J Med Econ. 2013. PMID: 23834480 Free article.

5

A model of mild hypoglycemia.

Samuel S, Goswami D, Shum K, Boye KS, Rengarajan B, Curtis B, Curtis SE. Samuel S, et al. Among authors: boye ks. Curr Med Res Opin. 2015 Apr;31(4):633-41. doi: 10.1185/03007995.2015.1020363. Epub 2015 Mar 17. Curr Med Res Opin. 2015. PMID: 25690489

6

Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK.

Gelhorn HL, Poon JL, Davies EW, Paczkowski R, Curtis SE, Boye KS. Gelhorn HL, et al. Among authors: boye ks. Patient Prefer Adherence. 2015 Nov 9;9:1611-22. doi: 10.2147/PPA.S90842. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26635470 Free PMC article.

7

Physician perceptions of GLP-1 receptor agonists in the UK.

Matza LS, Curtis SE, Jordan JB, Adetunji O, Martin SA, Boye KS. Matza LS, et al. Among authors: boye ks. Curr Med Res Opin. 2016 May;32(5):857-64. doi: 10.1185/03007995.2016.1147025. Epub 2016 Feb 12. Curr Med Res Opin. 2016. PMID: 26807507

8

Dulaglutide in the treatment of adult type 2 diabetes: a perspective for primary care providers.

Anderson JE, Thieu VT, Boye KS, Hietpas RT, Garcia-Perez LE. Anderson JE, et al. Among authors: boye ks. Postgrad Med. 2016 Nov;128(8):810-821. doi: 10.1080/00325481.2016.1218260. Epub 2016 Aug 12. Postgrad Med. 2016. PMID: 27488824 Review.

9

Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database.

Boye KS, Curtis SE, Lage MJ, Garcia-Perez LE. Boye KS, et al. Patient Prefer Adherence. 2016 Aug 16;10:1573-81. doi: 10.2147/PPA.S107543. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27574406 Free PMC article.

10

Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population.

Boye KS, Botros FT, Haupt A, Woodward B, Lage MJ. Boye KS, et al. Diabetes Ther. 2018 Apr;9(2):637-650. doi: 10.1007/s13300-018-0377-5. Epub 2018 Feb 19. Diabetes Ther. 2018. PMID: 29460259 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters